MedPath

A clinical study to evaluate the influence of strength of satva in Pulmonary Tuberculosis patients

Not Applicable
Conditions
Health Condition 1: A150- Tuberculosis of lung
Registration Number
CTRI/2022/04/041912
Lead Sponsor
Institute of Medical Science Banaras Hindu University Varanasi Uttar Pradesh India
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Confirmed pulmonary tuberculosis patients irrespective of gender

2.Patients with well controlled comorbid conditions

3.Age group between 18-70 years

Exclusion Criteria

1.Not willing to complete the consent process as describe in proforma.

2.Inability to comply with study procedures and methods.

3.HIV patients

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the type of Satva and its role in response to the treatment of Pulmonary Tuberculosis.Timepoint: 1.5yr
Secondary Outcome Measures
NameTimeMethod
To evaluate the association of types of Satva with adverse reactions and complications of Pulmonary Tuberculosis.Timepoint: 1.5 yr <br/ ><br>
© Copyright 2025. All Rights Reserved by MedPath